Integrum (INTEG B) Stock Overview
Researches, develops, and sells various systems for bone-anchored prostheses. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
INTEG B Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Integrum AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 9.76 |
| 52 Week High | SEK 43.15 |
| 52 Week Low | SEK 8.02 |
| Beta | 0.33 |
| 1 Month Change | -6.15% |
| 3 Month Change | 15.64% |
| 1 Year Change | -44.86% |
| 3 Year Change | -71.34% |
| 5 Year Change | -77.04% |
| Change since IPO | -56.62% |
Recent News & Updates
Recent updates
Revenues Tell The Story For Integrum AB (publ) (STO:INTEG B) As Its Stock Soars 99%
Jul 23
We're Hopeful That Integrum (STO:INTEG B) Will Use Its Cash Wisely
Jul 23Market Might Still Lack Some Conviction On Integrum AB (publ) (STO:INTEG B) Even After 26% Share Price Boost
May 22
US Sales Focus And Axor II Will Boost Market Outlook
Strategic focus on U.S. market growth and marketing optimization is expected to boost revenue and improve net margins.We're Not Very Worried About Integrum's (STO:INTEG B) Cash Burn Rate
Dec 05Slammed 38% Integrum AB (publ) (STO:INTEG B) Screens Well Here But There Might Be A Catch
Aug 30We Think Integrum (STO:INTEG B) Can Easily Afford To Drive Business Growth
May 03Does Integrum (STO:INTEG B) Deserve A Spot On Your Watchlist?
Sep 20Shareholder Returns
| INTEG B | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -5.8% | -6.0% | 0.2% |
| 1Y | -44.9% | -25.3% | 5.2% |
Return vs Industry: INTEG B underperformed the Swedish Medical Equipment industry which returned -25% over the past year.
Return vs Market: INTEG B underperformed the Swedish Market which returned 4.2% over the past year.
Price Volatility
| INTEG B volatility | |
|---|---|
| INTEG B Average Weekly Movement | 7.0% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in SE Market | 11.6% |
| 10% least volatile stocks in SE Market | 3.0% |
Stable Share Price: INTEG B has not had significant price volatility in the past 3 months compared to the Swedish market.
Volatility Over Time: INTEG B's weekly volatility has decreased from 19% to 7% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1990 | 37 | Martin Hillsten | integrum.se |
Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads.
Integrum AB (publ) Fundamentals Summary
| INTEG B fundamental statistics | |
|---|---|
| Market cap | SEK 260.28m |
| Earnings (TTM) | -SEK 29.85m |
| Revenue (TTM) | SEK 102.58m |
Is INTEG B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INTEG B income statement (TTM) | |
|---|---|
| Revenue | SEK 102.58m |
| Cost of Revenue | SEK 29.24m |
| Gross Profit | SEK 73.34m |
| Other Expenses | SEK 103.19m |
| Earnings | -SEK 29.85m |
Last Reported Earnings
Oct 31, 2025
Next Earnings Date
Mar 05, 2026
| Earnings per share (EPS) | -1.12 |
| Gross Margin | 71.50% |
| Net Profit Margin | -29.10% |
| Debt/Equity Ratio | 0% |
How did INTEG B perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/02/02 13:47 |
| End of Day Share Price | 2026/02/02 00:00 |
| Earnings | 2025/10/31 |
| Annual Earnings | 2025/04/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Integrum AB (publ) is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ulrik Trattner | DNB Carnegie Commissioned Research |